Skip to content
2000
Volume 5, Issue 11
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

To deliver on the promise of personalized medicine requires the integration of pharmacogenomics into the discovery and development of medicines. Over the last few years the pharmaceutical industry has been building considerable resources to achieve that. However, this requires new skill sets, capabilities and infrastructures which have not been a traditional part of the industry's efforts. In this article we describe how the integration of genetics and pharmacogenomics data has begun to deliver success and illustrate the challenges that the new science and technologies bring and how these challenges can be addressed in order to deliver on the promise.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802605774297047
2005-09-01
2025-04-19
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802605774297047
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test